CME/CNE Information

Claiming credit

Needs Statement

Novel Coronavirus SARS-CoV-2, the agent responsible for coronavirus disease 2019 (COVID-19), is producing a growing public health emergency in China and elsewhere in the world. As the numbers of confirmed cases and deaths continue to rise, clinical details of COVID-19 disease have become available through case reports and public health partners. However, the complete clinical spectrum is not yet fully understood, and health care providers may not be familiar with the most recent information related to the clinical course, diagnostic tests, and state of treatment strategies for this infection. There is also a need to educate health care providers on the key measures that hospitals and clinics can utilize to prepare for handling Persons Under Investigation (PUI) and reduce exposure of healthcare personnel as well as others. This activity aims to update health care providers regarding the state of the epidemiology, diagnosis, clinical course, and state of treatment strategies for COVID-19 disease caused by the SARS-CoV-2 virus. The activity also aims to provide health care providers with guidance on handling PUI to reduce the risk of transmission.

Objectives

At the conclusion of the session, the participants should be able to:

  • Identify patients who should be evaluated as patients under investigation for SARS-CoV-2 infection
  • Incorporate the appropriate procedures for patient isolation, handling and diagnostic testing for patients with suspected COVID-19 disease caused by SARS-CoV-2 infection in their clinics
  • Describe the state of the recommended treatment and supportive care strategies for patients with confirmed COVID-19 disease
  • Discuss drugs and vaccines in development against the SARS-CoV-2 virus

Target Audience

  • Physicians
  • Advanced Professionals
  • Fellows
  • Residents
  • Nurses
  • Other Health Professionals

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CHI St. Luke's Health Baylor St. Luke's Medical Center is approved as a provider of nursing continuing professional development by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Program Director

Laila Eugenia Woc-Colburn, M.D.
Associate Professor
Department of Medicine, Infectious Disease
Director of Medical Education
National School of Tropical Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: McGraw Hill, Elsevier – Intellectual property
ASTMH, ISDA – Honorarium recipient

Faculty

Laila Eugenia Woc-Colburn, M.D.
Associate Professor
Department of Medicine, Infectious Disease
Director of Medical Education
National School of Tropical Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: McGraw Hill, Elsevier – Intellectual property
ASTMH, ISDA – Honorarium recipient
Mayar Al Mohajer, M.D.
Associate Professor
Department of Medicine, Infectious Disease
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose
Peter Hotez, M.D., Ph.D.
Dean, National School of Tropical Medicine
Professor, Departments of Pediatrics, Molecular Virology & Microbiology
Co-Head, Section of Pediatric Tropical Medicine
Health Policy Scholar
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose
Maria Elena Bottazzi, Ph.D.
Associate Dean, National School of Tropical Medicine
Professor, Departments of Pediatrics, Molecular Virology & Microbiology
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose
Amy Spallone, M.D.
Fellow
Department of Medicine, Infectious Disease
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to Disclose
David McCormick, M.D.
Resident
Department of Medicine, Infectious Disease
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to Disclose

Peer Reviewer

Robert Legare Atmar, M.D.
Professor
Department of Medicine, Infectious Disease
Baylor College of Medicine
Houston, Texas
Disclosure: Takeda Vaccines, Inc – Research support
Seres Therapeutics, Inc – Data Monitoring Committee

Term of Approval

February 10, 2020 through February 28, 2021. Original release date: February 10, 2020.

Disclaimer

The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.

Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.

Claiming Credit

You may claim CME credit after reviewing each of the four modules, completing the posttest with a 70% passing rate, and registering for credit.

Modules

All Clinicians Nurses Only

* On February 11, 2020, the World Health Organization named the novel coronavirus disease “COVID-19”. The agent responsible for COVID-19 is the novel coronavirus, SARS-CoV-2.